Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
eazyScripts
AddedFeb 16, 2024
UpdatedJun 18, 2026
eazyScripts

eazyScripts

Series A

eazyScripts: Efficient telemedicine software for electronic prescriptions, data checks, and improved patient care.

HQ
Chicago, IL, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to streamline telemedicine services, eazyScripts provides a comprehensive software solution for electronic prescriptions. The platform allows telemedicine providers to submit electronic prescriptions, check prescription fill data, access formulary information, and secure electronic prior authorizations efficiently. By enabling providers to send prescriptions in 25 seconds or less, eazyScripts aims to reduce inefficiencies and errors, ultimately enhancing patient care and satisfaction.

Notable figures affiliated with eazyScripts include key investors and industry experts who have recognized the platform's potential to revolutionize telemedicine. The company has achieved significant milestones, such as increasing medication adherence and improving patient satisfaction rates. eazyScripts' impact is evident in its ability to allow healthcare providers to focus more on patient health outcomes, making it a valuable tool in the telehealth industry.

eazyScripts - Similar Companies

ScriptDrop logo

ScriptDrop

scriptdrop.co

ScriptPad logo

ScriptPad

SmartScripts logo

SmartScripts

smartscripts.com

DrFirst.com logo

DrFirst.com

drfirst.com

eVisit logo

eVisit

evisit.com

Ezdoctor logo

Ezdoctor

Text2MD logo

Text2MD

text2md.com

Prescribe logo

Prescribe

GetDoctor logo

GetDoctor

getdoctor.co

DocStation logo

DocStation

docstation.co

RxLive logo

RxLive

rxlive.com

RxVantage logo

RxVantage

rxvantage.com

Docty logo

Docty

docty.ai

TeleQ logo

TeleQ

RxLightning logo

RxLightning

rxlightning.com

eazyScripts - Quick Facts

Who are eazyScripts' competitors?

Companies similar to eazyScripts include ScriptDrop, ScriptPad, SmartScripts and DrFirst.com.

When was eazyScripts founded?

eazyScripts was founded in 2014.

Where is eazyScripts' headquarters located?

eazyScripts' headquarters is located in Chicago, IL, US.

When was eazyScripts' last funding round?

eazyScripts' most recent funding round was for $2M (USD) in August 2017.

How much has eazyScripts raised to-date?

As of Aug 2, 2017, eazyScripts has raised a total of $2M (USD).

How many employees does eazyScripts have?

eazyScripts has 6 employees as of Feb 4, 2024.

eazyScripts - Classification

Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Software
  • Telemedicine
Tags
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
SIC
  • 8060Hospitals